A $4B MLB club plus regional network is heading into a $26B sports and media empire, resetting the bar for RSN-era valuations.

The national health insurance nod could accelerate adoption of regenerative therapies for heart disease, opening a new era for cell-based medicine.

The Queens rapper joins a celebrity panel for the SBA's Million Dollar Pitch Competition in Washington on Sept. 18.

A 27-year peak in the cost of long-term borrowing is rewriting the Budget math before the plan has even been written.

As the GLP-1 market heats up, Novo Nordisk's chief insists Wall Street is missing the full value of its weight-loss and diabetes portfolio.

Three global banks host conferences in the Chinese tech hub, signaling a shift in capital flows toward the country's advanced manufacturing and AI sectors.

The Shanghai opening shows China's appetite for affordable indulgences, with queue-sitting out-pricing the bucket and a 600-restaurant expansion plan.

The Canadian auto supplier's latest $35M injection cements its control of Yuma Energy as India's EV ecosystem pivots to battery swapping.

The e-commerce giant responds to a sweeping antitrust suit, arguing the agency's case rests on a flawed view of its advertising business.

The regulator says Amazon quietly raised ad prices for businesses - here's what it means for sellers and Amazon's ad empire.

The legacy app's political stand turned a naming dispute into a user-driven surge, reshaping competitive dynamics in navigation.

Citigroup projects a $12 trillion market cap for SpaceX, but banks' lofty price targets ignore the company's struggle to reach public-market exit velocity. Here's what the research really says.